<_value> Survey on Drugs and Fatal Road Traffic Accidents SAM FRESH-PEF8489-en 8489 FRESH-PEF8489 Bernard LAUMON INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) UNIVERSITE GUSTAVE EIFFEL OBSERVATOIRE FRANCAIS DES DROGUES ET DES TENDANCES ADDICTIVES (OFDT) CTRE EUR ETUD SECURITE ANALYSES RISQUES (CEESAR) Epidemiology France Portal (PEF) DGC PSA PEUGEOT CITROEN (FRANCE) CTRE EUR ETUD SECURITE ANALYSES RISQUES (CEESAR) INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) OBSERVATOIRE FRANCAIS DES DROGUES ET DES TENDANCES ADDICTIVES (OFDT) Renault (France) UNIVERSITE GUSTAVE EIFFEL null Bernard;LAUMON CNIL liability blood alcohol drug addiction drugs road traffic accidents road safety mortality risk Neurology Psychiatry Addiction medicine Behavioral determinants: Addiction Healthcare system determinants: Use of care Behavioral determinants Healthcare system determinants The epidemiological analysis aims to assess the role played by drugs in fatal road accidents. This includes estimating the relative risk of fatal accidents that involve drugs and the prevalence of drugs among "circulating" (accident-free) drivers. Even though only drivers involved in a fatal accident are included, both of these parameters may be estimated, provided certain analysis conditions are met. It also aims to characterise fatal accidents involving drivers under the influence and to compare these characteristics with those from other fatal accidents. The objective is to determine whether the first accident type bears specific traits that may be the basis for defining preventative initiatives that target drug users. null France Individuals General population Male Female Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) Present at the accident with immediate life-threatening consequences; - Consent. Biological data Health event/mortality One-time cross-sectional study Other [1000-10000[ individuals Converting or copying information into a structured record Interview with the participant (including clinical) Observational Study Observational Study 16,534 drivers. Completed study Restricted access Contact the principal investigator Access on specific project only